Samit Hirawat

CIK: 0001781290

Transaction Breakdown

Open Market Buys (P)3 (15.8%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (21.1%)

Derivative conversions

Awards (A)4 (21.1%)

Compensation grants

Other (G, F, J, C, D, …)8 (42.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

IAM

Iambic Therapeutics, Inc.

Director

PCRX

Pacira BioSciences, Inc.

Director

BMY

BRISTOL MYERS SQUIBB CO

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

PCRX
Pacira BioSciences, Inc.
Jun 10, 2026
Award(A)
Direct
6.4K shares-
PCRX
Pacira BioSciences, Inc.
Jan 27, 2026
Award(A)
Stock Option (Right to Buy)
Direct
39.3K shares-
BMY
BRISTOL MYERS SQUIBB CO
Apr 25, 2025
Purchase(P)
Direct
4.3K shares at avg. $47.58$202K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
4.9K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
4.8K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
831 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Tax Payment(F)
Direct
2K shares at avg. $63.11$127K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
5.9K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
998 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $63.11$157K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
28.6K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
10.5K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Tax Payment(F)
Direct
9.2K shares at avg. $63.11$583K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Award(A)
Performance Shares
Direct
52.7K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Tax Payment(F)
Direct
2.3K shares at avg. $63.11$147K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
337 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Award(A)
Market Share Units
Direct
35.1K shares-
BMY
BRISTOL MYERS SQUIBB CO
Feb 14, 2025
Purchase(P)
Direct
1.8K shares at avg. $54.84$100K
BMY
BRISTOL MYERS SQUIBB CO
Nov 1, 2024
Purchase(P)
Direct
1.8K shares at avg. $54.67$100K

		Type	Shares	Price		Ownership
Jun 10, 2026	PCRX Pacira BioSciences, Inc.	Award(A)	6,405	-	$0	Direct
Jan 27, 2026	PCRX Pacira BioSciences, Inc.	Award(A) Stock Option (Right to Buy)	39,291	-	-	Direct
Apr 25, 2025	BMY BRISTOL MYERS SQUIBB CO	Purchase(P)	4,250	$47.58	$202,215	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	4,886	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	4,765	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	831	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	2,013	$63.11	$127,040	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	5,854	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	998	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	2,484	$63.11	$156,765	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	28,593	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	10,545	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	9,232	$63.11	$582,632	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Award(A) Performance Shares	52,720	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	2,327	$63.11	$146,857	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	337	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Award(A) Market Share Units	35,146	-	-	Direct
Feb 14, 2025	BMY BRISTOL MYERS SQUIBB CO	Purchase(P)	1,823	$54.84	$100,000	Direct
Nov 1, 2024	BMY BRISTOL MYERS SQUIBB CO	Purchase(P)	1,830	$54.67	$100,055	Direct

1-19 of 19 transactions

About Hirawat Samit

Hirawat Samit (SEC CIK 0001781290) files insider reports with the SEC as Director of Iambic Therapeutics, Inc. (IAM), Director of Pacira BioSciences, Inc. (PCRX) and EVP,Chief Med.Offr.,Drug Dev. of BRISTOL MYERS SQUIBB CO (BMY).

Signal8 holds 8 ownership filings by Hirawat Samit (2 Form 3, 6 Form 4), filed between Nov 5, 2024 and Oct 14, 2026. Those filings report 19 transactions, from Nov 1, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hirawat Samit's filings is in SAN DIEGO, CA.

Recent filings by Hirawat Samit

Jun 10, 2026: Grant or award of PCRX shares (Form 4, code A).
Jan 27, 2026: Grant or award of PCRX derivative securities (Form 4, code A).
Apr 25, 2025: Open-market purchase of BMY shares (Form 4, code P).
Mar 10, 2025: Option exercises of BMY shares (2 lines, Form 4, code M).
Mar 10, 2025: Other transaction of BMY shares (Form 4, code J).

Other insiders filing for Iambic Therapeutics, Inc. (IAM)

Catalio Capital Management, LP, 10% Owner
Vogelstein R Jacob, Director
Secora Michael, CFO & Chief Corp Dev Ofcr
RASTETTER WILLIAM H, Director
Rachlin Evan Lockwood, Director
EMSTER KURT VON, Director

How to read Form 4 transaction codes